Business NewsMarketWire • Equity Research on Mylan Inc. and Watson Pharmaceuticals Inc. -- Generic Pharmaceuticals Future Continues to Look Bright

Equity Research on Mylan Inc. and Watson Pharmaceuticals Inc. -- Generic Pharmaceuticals Future Continues to Look Bright

Equity Research on Mylan Inc. and Watson Pharmaceuticals Inc. -- Generic Pharmaceuticals Future Continues to Look Bright

JOHANNESBURG, SOUTH AFRICA--(Marketwire - Jun 3, 2011) - www.stockcall.com/ offers investors comprehensive research on the Drugs - Generic industry and has completed analytical research on Mylan Inc. (NASDAQ: MYL) and Watson Pharmaceuticals Inc. (NYSE: WPI). Register with us today at www.stockcall.com/ to have free access to these researches.

View More : http://www.marketwire.com/mw/release.do?id=1522416&sourceType=3
Releted News by marketwire
Just Energy Group Inc. Announces June Dividend
Equity Research on St. Jude Medical Inc. and Medtronic Inc. -- Good News and Bad for Medical Appliances and Equipment Sector
Equity Research on Mylan Inc. and Watson Pharmaceuticals Inc. -- Generic Pharmaceuticals Future Continues to Look Bright